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Abstract
Real-time or quantitative PCR (qPCR) is a useful technique that requires reliable reference
genes for data normalization in gene expression analysis. Adipogenesis is among the bio-
logical processes suitable for this technique. The selection of adequate reference genes is
essential for qPCR gene expression analysis of human Vascular Stromal Cells (hVSCs)
during their differentiation into adipocytes. To the best of our knowledge, there are no stud-
ies validating reference genes for the analyses of visceral and subcutaneous adipose tissue
hVSCs from subjects with different Body Mass Index (BMI) and Homeostatic Model Assess-
ment of Insulin Resistance (HOMA-IR) index. The present study was undertaken to analyze
this question. We first analyzed the stability of expression of five potential reference genes:
CYC, GAPDH, RPL13A, EEF1A1, and 18S ribosomal RNA, during in vitro adipogenic differ-
entiation, in samples from these types of patients. The expression of RPL13A and EEF1A1
was not affected by differentiation, thus being these genes the most stable candidates,
while CYC,GAPDH, and 18S were not suitable for this sort of analysis. This work highlights
that RPL13A and EEF1A1 are good candidates as reference genes for qPCR analysis of
hVSCs differentiation into adipocytes from subjects with different BMI and HOMA-IR.
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Introduction
The mechanisms underlying insulin resistance (IR) and type 2 diabetes (T2D) development
in obese subjects are not fully understood. Thus, there is currently an intense research aiming
to understand the mechanisms underlying these processes [1,2]. Several lines of evidence
indicate that the physiopathology of these diseases involves mechanisms other than only fat
accumulation. Indeed, this paradox can be seen in the fact that some morbidly obese subjects
do not develop IR and/or diabetes, whereas some lean subjects do. In this line, several studies
have been focused on the analysis of adipose tissue (AT) expansion capacity as one of the
driving factors in the development of these metabolic disorders. The expandability hypothesis
states that the capacity to expand of the fat depots are not the same for all subjects and once
the limit of storage capacity is exceeded, the lipids are accumulated ectopically in other
organs, inducing the secretion of pro-inflammatory factors that drive to insulin resistance
and further T2D development [3,4]. This expansion capacity depends on the resident stem
cells and on their capacity to differentiate into adipocyte cell lineages [3,5]. Gene expression
analyses by qPCR are among the current widely used techniques to investigate these mecha-
nisms, being necessary to reliably detect small changes in gene expression during the AT
expansion and adipocyte differentiation. Reference genes are commonly used as internal con-
trols to quantify changes in mRNA levels [6]. These controls are required to avoid variations
in RNA quality, content and stability, reaction efficiency, and sample loading [7]. This vari-
ability can also be further increased among samples from different subjects, tissues and time
courses, leading to data misinterpretation. Therefore, it is peremptory to identify and validate
reliable reference genes for qPCR analysis [8]. Given that there is no universal reference gene
for all biological processes [9], the use of multiple stable reference genes is the widely accepted
method for qPCR data normalization [8,10,11].
GAPDH and β-Actin are the most widely used reference genes. However, their expression
is known to be influenced by developmental and environmental factors. Other studies have
used GAPDH and Ribosomal Protein L13A (RPL13A) for adipogenesis and osteogenesis in
bone marrow stem cell differentiation [12,13]. Other study has used RPL13A and EF1α for
Marrow-Isolated Adult Multilineage Inducible (MIAMI) and Recycling Stem (RS-1) cells
[14]. RPL13A was also shown to be reliable for the analysis of bone marrow- and placenta-
derived MSCs during expansion, adipo-, chondro-, and osteo-genesis, in primary Human
Bone Cells (HBCs), and in the osteosarcoma cell line MG-63 [15]. Amable et al. studied five
genes in human MSCs from liposuction of abdominal fat, and found that RPL13A was the
most appropriate reference gene [11]. The 18S gene has been used as reference for human
subcutaneous adipose tissue derived pre-adipocytes [16,17]. However, its expression
stability has not been yet validated. Ferguson et al. studied the expression of six genes in the
3T3-L1 cell line under four experimental conditions (inflammatory stress, oxidative stress,
cell cycle progression and differentiation), and found that the 18S is the most reliable refer-
ence gene [18].
To date, there are no validated reference genes for adipogenic differentiation of mesenchy-
mal cells either from human Visceral Adipose Tissue (VAT) and Subcutaneous Adipose Tissue
(SAT) isolated from subjects with different BMI and HOMA-IR. Given the importance of the
understanding of the mechanisms involved in the adipogenic differentiation in human AT,
and the potential variability of reference genes depending on the source of this tissue and dis-
ease status, it is essential to have available validated reference genes to reliably study these pro-
cesses. The present work was undertaken to analyze this question.
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Materials and Methods
Patients
AT samples were extracted from morbidly obese patients (n = 8) undergoing bariatric surgery
at the Virgen de la Victoria Clinical University Hospital (Malaga, Spain). Exclusion criteria:
Subjects with diabetes mellitus type 2 treated with insulin, with cardiovascular disease in the 6
months prior to the inclusion in the study, with any evidence of acute or chronic inflammatory
disease, with infectious disease or patients’ refusal to participate in the study. Non-morbidly
obese subjects (n = 8) who underwent laparoscopic surgery for hiatus hernia or cholelithiasis,
matched by age to the obese group, acted as controls. Exclusion criteria for control subjects
were the same as for the morbidly obese patients. The study groups were classified as follows:
Lean/L-IR; subjects with BMI 18.5–24.9 and a low degree of insulin resistance
(HOMA-IR<3.5), Lean/H-IR; subjects with BMI 18.5–24.9 and a high degree of insulin resis-
tance (HOMA-IR>7), MO/L-IR; morbidly obese subjects (BMI>40) with a low degree of insu-
lin resistance (HOMA-IR<3.5), MO/H-IR; morbidly obese subjects (BMI>40) with a high
degree of insulin resistance (HOMA-IR>7). The cut-off point for HOMA-IR was set at 3.5
using 90th percentile criteria in a Spanish population [19]. All participants gave their written
informed consent, and the study was reviewed and approved by the Ethics and Research Com-
mittee of the Virgen de la Victoria Clinical University Hospital. The average age of each group
and their anthropometric and biochemical characteristics are shown in Table 1. Both subcuta-
neous and visceral adipose tissues (SAT and VAT) were obtained at the beginning of the surgi-
cal procedure and were stored immediately at -80°C.
AT collection and experimental design
The stromal vascular fraction (SVF) was isolated from VAT (n = 16) and SAT (n = 16) imme-
diately after their extraction. SVF cells were in vitro induced to differentiate into adipocytes
and the total mRNA was isolated from the 64 samples (32 from undifferentiated cells and 32
from differentiated adipocytes). Adipocyte differentiation was assessed by oil red O-staining,
which was performed by fixing the cells in neutral buffered formalin, followed by staining of
intracellular lipid droplets with a 30% in PBS solution of Oil Red O (Thermo Fisher (Kandel)
GmbH, Karlsruhe, Germany), prepared from a stock solution of Oil Red O 0.5% in isopropa-
nol, and by the mRNA expression of the adipocyte markers FABP4 and PPARγ2. Ct analysis
Table 1. Anthropometric, clinical andmetabolic characterization of patients. Donors (n = 16) were selected according to BMI and HOMA-IR. Data are
expressed as the mean ± SEM. Comparison among groups was performed by Kruskal-Wallis and Mann-Whitney tests. Note that in each arrow, "a" and "b"
letters in superscript represent statistically different groups. L-IR: Low-degree insulin resistance, H-IR: High-degree insulin resistance. DAP: Diastolic Arterial
Pressure, SAP: Systolic Arterial pressure.
Lean L-IR (n = 4) Lean H-IR (n = 4) Morbid obese MO- L-IR (n = 4) Morbid obese MO- H- IR (n = 4)
Age (Years) 51.68±15.96 47.53±12.11 43.64±10.70 38.42±9.20
BMI 23.11±1.59a 24.21±1.13a 57.13±8.40b 57.59±6.60b
Waist Circumference(cm) 83.76±7.90a 85.12±5.40a 142.80±21.77b 149.00±25.53b
Triglycerides (mM) 1.16±0.53a 1.64±1.21b 1.19±0.50a 1.67±1.05b
Cholesterol (mM) 5.20±1.18 4.77±1.01 5.39±1.52 4.96±0.67
HDL cholesterol (mM) 1.47±0.52a 1.52±0.41a 0.93±0.68b 0.98±0.47b
SAP (mmHg) 121.47±11.78 129.67±10.71 134.40±22.51 142.67±25.87
DAP(mmHg) 68.47±9.91a 72.23±8.18a 82.40±10.90b 86.33±17.28b
HOMA IR 1.11±0.84a 10.33±4.52b 3.32±0.82a 12.54±4.97b
Adiponectin (μg/mL) 13.55±5.81a 14.65±4.76a 10.83±4.88b 9.21±4.90b
doi:10.1371/journal.pone.0157002.t001
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for CYC, GAPDH, RPL13A, EEF1A1, and 18S genes was performed together with the analysis
of the change in Ct during differentiation. By this way, analysis of gene expression stability
among the studied groups and during differentiation was assessed. Finally, validation of our
findings was performed by the Bestkeeper algorithm and RefFinder platform.
Isolation of SVF from VAT and SAT
The reagents were purchased from Sigma (St. Louis, MO, USA) unless otherwise stated. The
Isolation of SVF from VAT and SAT was carried out using a modified procedure from Zuk
et al. [20]. Briefly, AT samples were transported in Hank's balanced salt solution supplemented
with penicillin and streptomycin. Samples were washed twice with PBS, fragmented, and enzy-
matically digested in a solution containing type II collagenase and bovine serum albumin
(BSA) for 20 min at 37°C on a shaking water bath. The resulting cell suspension was centri-
fuged at 500xg for 10 min. Floating adipocytes were discarded and the precipitate containing
the SVF was filtered through a 100 μmmesh, and centrifuged at 400xg for 5 min. The cell pel-
lets were resuspended in an hypotonic buffer to lysate the erythrocytes for 10 min at room tem-
perature and centrifuged again at 400xg for 5 min. Cell pellets were then suspended in
expansion medium DMEM/F12 supplemented with 10% fetal bovine serum, 100 μg/ml strep-
tomycin, 100 U/ml penicillin, 2 mM L-glutamine, and 1 μg/ml amphotericin B. Cells were then
plated into tissue culture flasks and incubated at 37°C in a humid atmosphere with 5% of CO2
for approximately 8 days until 90% of confluence was reached.
Adipogenic differentiation
Adipogenic differentiation was carried out as previously described [21,22]. Briefly, cells were
induced to differentiate between passages two and three. SVF cells from both tissues were
seeded in 12 and 96 well plates at a density of 10.000 cells per cm2 in human preadipocyte
medium (DMEM/Hams F-12 medium (1:1, vol/vol), 20mMHEPES pH 7.4 supplemented with
10% fetal bovine serum, 1% penicillin and streptomycin). The preadipocyte medium was
replaced every 2–3 days upon reaching 90% confluence and then replaced with adipogenic
medium on the 21st day. During the first three days the induction medium was DMEM/Hams
F-12 medium (1:1, vol/vol), 20 mMHEPES pH 7.4 supplemented with 10% fetal bovine serum,
33μM biotin, 17μM pantothenate, 10μM human insulin, 1μM dexamethasone, 0.5mM IBMX,
10μM pioglitazone, 0.5μM rosiglitazone, 1% penicillin/streptomycin and 1μg/ml amphotericin
B. Then, the medium was replaced by adipogenic medium: DMEM/Hams F-12 medium (1:1,
vol/vol), 20mMHEPES pH 7.4 supplemented with 10% fetal bovine serum, 10μM human insu-
lin, 1μM dexamethasone, 10μM pioglitazone, 0.5μM rosiglitazone. After one week of the adipo-
cyte differentiation, cells were collected and processed for mRNA extraction and qPCR.
mRNA extraction and qPCR
Total RNA was isolated using the RNA Stat 60 Reagent (Ams Biotechnology, Abingdon, UK).
Total RNA was quantified using NanoDrop ND-1000 spectrophotometer V3.7.1 (Thermo Sci-
entific, Massachusetts, MA, USA). RNA purity was assessed by checking the absorbance at 260
nm, 280 nm and 230 nm. A ratio A260/A280<1.8 indicates protein contamination and<2
presence of phenol, chaotropic salts (guanidinium thiocyanate) or proteins.
RNA was reverse transcribed using Transcriptor reverse Transcriptase (Roche Diagnostic,
Barcelona, Spain). cDNA amplifications were carried out using a MicroAmp1 fast optical
96-well reaction plate (Applied Biosystems, CA, USA) on an Applied Biosystems 7500 Fast
Real-Time PCR System. Quantitative RT-PCR reactions were carried out for all genes using
specific TaqMan1 probes (Applied Biosystems, CA, USA) (S1 Table). PCR reactions were run
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in duplicate. A PCR negative control (without template) and positive control (with a template
of known amplification) were included in each assay. During the PCR, the Ct values for each
amplified product were determined using a threshold value of 0.1.
Determination of the expression and stability of the reference genes
To determine the expression and stability of the candidate reference genes in the different
groups and during differentiation, two different approaches were used: Firstly, we performed a
Ct analysis over the raw non-normalized data and assessed the changes in ΔCt during adipo-
genesis and, secondly, we validated the findings by the Bestkeeper algorithm and RefFinder
platform. For the study of putative changes in reference genes during differentiation, they were
analyzed and validated using the criterion of ΔCt value ±0.5 as a delimiter of reference gene
suitability. For each tissue sample, expression stability of each gene was calculated using the
mean of the Ct values and all validation data were converted into fold-changes using the for-
mula 2-ΔCt. It is widely accepted that reference gene expression levels that fall in between 0.7
and 1.4 are considered fluctuation in gene expression that are due to technical variance [23].
BestKeeper is an excel-based tool using pair-wise correlations which determines the best suited
standards, out of ten candidates, and combines them into an index, being one of the most
appropriate tool for the validation of a first screening [24]. The Bestkeeper software was down-
loaded from http://www.gene-quantification.de/bestkeeper.html and used according to the
developer’s instructions. BestKeeper identifies the reference genes when they exhibit the lowest
Standard Deviation (SD) and highest Pearson correlation coefficient (r). Genes that show a SD
greater than 1 are considered unacceptable [24]. The BestKeeper index is the geometric mean
of the Ct values of the highly correlated candidate reference gene. Descriptive statistics of the
derived crossing points are calculated for each reference gene: the Geometric Mean (GM),
Arithmetic Mean (AM), Minimal (Min) and Maximal (Max) value, Standard Deviation (SD),
and Coefficient of Variance (CV). All crossing point data are compared over the entire study,
considering the different groups. The X-fold over- or under-expression of individual samples
towards the geometric mean crossing point (2-ΔCt) are calculated, and the multiple factors of
their minimal and maximal values are expressed as the x-fold ratio and its standard deviation.
RefFinder, which integrates the currently available major computational softwares (geNorm,
Normfinder, BestKeeper, and the comparative Ct method), was used to verify the comparative
results obtained from Bestkeeper and ΔCt analysis carried out for this work [25]. RefFinder
was downloaded from http://fulxie.0fees.us/ and used according to the developer’s
instructions.
Statistical analysis
Clinical parameters and gene expression data are expressed as means ± SEM, except Ct data
which have been represented by boxplots with median and 97.5 percentile. Normality tests
were performed by Shapiro-Wilk test. The Levene’s test was used to determine homogeneity of
variance. Kruskal-Wallis and Mann-Whitney tests were used to compare mean among the
groups presented in Table 1, and one-way or two-way ANOVA test, following Bonferroni
post-hoc test to the data of Table 2 and Figs 1 and 2. In all cases, the rejection levels for a null
hypothesis were α = 0.05 for two tails. All statistical analysis were performed using the IBM
SPSS Statistic software program SPSS (v22.0. for Windows; Chicago, IL, USA).
Results
Table 1 shows the clinicopathological data of the study population. As expected, waist circum-
ference and diastolic arterial pressure were statistically increased in morbid obese subjects
RPL13A and EEF1A1 As Reference Genes for Adipocyte Differentiation
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Table 2. Descriptive analysis of Ct values variability from qPCR of Undifferentiated and differentiated hVSCs from VAT of patients with different
BMI and HOMA-IR index. The table shows the statistics min, max, mean ± SEM, standard variation (SD) and variance of the Ct values obtained after qPCR
of undifferentiated and differentiated VAT-derived hVSCs in the four groups under investigation as well as the mean values for every reference gene
assessed (right columns). Data show that RPL13A and EEF1A1 has the lowest variability (SD and variance values) suggesting more stability in their expres-
sion when compared to the other reference genes. VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue. Lean L-IR: lean subjects with low-
degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR: morbid obese subjects with low-degree insulin resistance;
MO H-IR: morbid obese with high-degree insulin resistance.
RPL13A in VAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 22.99 22.68 23.49 24.59 22.66 23.49 22.36 22.3 23.07
Max 24.82 24.01 25.14 24.95 25.41 25.48 23.42 23.38 24.58
Mean ±SEM 23.85±0.43 23.35±0.35 24.4±0.4 24.8±0.08 23.88±0.57 24.16±0.45 22.84±0.24 22.91±0.26 23.77±0.35
SD 0.85 0.71 0.81 0.16 1.15 0.89 0.47 0.52 0.70
Variance 0.73 0.5 0.66 0.027 1.31 0.8 0.22 0.27 0.56
EEF1A1 in VAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 17.79 17.19 17.38 17.58 17.53 18.03 17.05 18.10 17.58
Max 20.13 19.02 18.02 19.22 19.58 20.78 18.51 19.05 19.29
Mean ±SEM 18.73±0.49 18.23±0.39 17.77±0.14 18.16±0.37 18.69±0.5 19.23±0.62 17.75±0.31 18.57±0.24 18.39±0.38
SD 0.99 0.78 0.28 0.74 0.99 1.24 0.61 0.49 0.77
Variance 0.98 0.62 0.08 0.55 0.98 1.53 0.37 0.24 0.67
CYC in VAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 22.13 21.12 22.04 21.34 22.12 21.12 22.16 22.07 21.76
Max 26.76 24.84 23.35 23.63 24.86 25.28 24.07 24.29 24.64
Mean ±SEM 23.98±0.99 23.53±00.82 22.87±0.29 22.65±0.48 23.52±0.58 23.53±0.88 23.1±0.39 23.32±0.55 23.31±0.62
SD 1.98 1.65 0.59 0.95 1.15 1.75 0.78 1.11 1.25
Variance 3.92 2.71 0.34 0.91 1.33 3.07 0.62 1.23 1.77
GAPDH in VAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 23.26 24.61 22.87 22.91 24.79 22.88 23.86 23.59 23.60
Max 28.23 27.30 26.84 23.71 26.81 25.12 26.95 26.23 26.40
Mean ±SEM 25.95±1.32 25.63±0.64 24.85±0.86 23.30±0.22 25.43±0.47 24.11±0.47 25.41±0.67 24.93±0.55 24.95±0.65
SD 2.63 1.28 1.73 0.45 0.95 0.94 1.34 1.1 1.30
Variance 6.93 1.63 2.99 0.2 0.9 0.89 1.79 1.22 2.07
18S in VAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 11.23 12.88 12.53 13.39 11.41 10.40 12.96 11.63 12.05
Max 15.65 14.59 15.73 15.85 13.61 16.26 16.31 14.04 15.26
Mean ±SEM 13.15±0.92 13.53±0.37 14.25±0.66 14.39±0.54 12.36±0.46 12.83±1.25 14.45±0.7 12.57±0.52 13.44±0.68
SD 1.84 0.74 1.31 1.07 0.92 2.5 1.39 1.04 1.35
Variance 3.39 0.55 1.73 1.16 0.86 6.27 1.94 1.09 2.12
doi:10.1371/journal.pone.0157002.t002
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compared to lean, while HDL cholesterol and adiponectin were decreased. On the other hand,
triglycerides levels were statistically increased in lean and morbid obese subjects with high
Insulin-Resistance degree (H-IR). In order to determine the expression stability during adipo-
cyte differentiation, human stromal vascular cells (hVSCs) from the ATs were induced to dif-
ferentiate into adipocytes. hVSCs differentiated into adipocytes, and lipid-filled cells were
detected with oil red O-staining (Fig 1A). Moreover, mRNA levels of PPARγ2 and FABP4 were
increased in differentiated cells from both VAT- and SAT compared to non-differentiated
hVSCs (Fig 1B and 1C), and higher levels of PPARγ2 and FABP4mRNA were detected in sam-
ples from obese patients when compared to lean subjects, independently of the associated insu-
lin resistance condition (MO L-IR or MO H-IR versus Lean L-IR or Lean H-IR). Additionally,
PPARγ2 levels in VAT were different in each group when compared to any other, with expres-
sion levels decreasing in the following way, MO H-IR>MO L-IR>Lean H-IR>Lean L-IR
(two-way ANOVA, Bonferroni's post hoc test). The mRNA expression levels of RPL3A,
EEF1A1, CYC, GADPH and 18S were assessed in both non-differentiated hVSCs and differenti-
ated adipocytes from the four groups of patients. Analysis of gene expression stability for the
candidate reference genes was done by three different approaches, and further validated by
BestKeeper analysis and RefFinder platform. First, the raw non-normalized Ct data were ana-
lyzed for variability. Tables 2 and 3, show the min, max, mean ± SEM, SD, and variance for
each reference gene and type of sample from VAT (Table 2) and SAT (Table 3). RPL13A and
EEF1A1 were the less variable genes in VAT with 0.70 and 0.77 SD values and 0.56 and 0.67
variance values, respectively, in contrast to values ranging from 1.25 to 1.35 (SD) and 1.77 to
2.12 (variance) for the other genes. A similar result was found in SAT, with SD values for
RPL13A and EEF1A1 of 0.93 and 0.85, respectively (the variance values were 1.08 and 0.87,
respectively) in contrast to SD and variance values for the other genes (SD ranged from 1.22 to
1.37 and variance ranged from 1.52 to 2.33). Boxplot representation of these data is shown in
Fig 2. Due to the small sample size and statistical purposes, the samples were grouped and com-
pared as lean vs obese, low-IR vs high-IR and VAT vs SAT. Statistical analysis (two-way
ANOVA) showed no differences between groups for any of the candidate reference genes.
Subsequently, to compare the expression levels of each reference gene, their mean difference
value (MD) were calculated as the difference of the Ct with the mean expression of the other
genes (mean Ct), and illustrated by plotting of the individual MD-value against mean Ct (Fig 3).
Precision is illustrated by the 2-fold standard deviation (±2SD). Table 4 shows in more detail
the level of expression for each reference gene among the different groups and adipose depots
(MD values and ±2SD). Statistical analysis (one-way ANOVA) showed no differences between
groups for any gene. Regarding the expression level, in VAT and SAT, the 18S showed the high-
est expression, with an MD-value of -9.17 and -9.56 (for VAT and SAT, respectively) and
GAPDH had the lowest expression level, with a MD-value of +5.22 and +5.89 (VAT and SAT,
respectively). Expression levels in VAT were 18S>EEF1A1>CYC> RPL13A>GAPDH, and in
SAT were 18S>EEF1A1>RPL13A>CYC>GAPDH. Precision ranged from 1.39 for RPL13A to
2.86 for 18S in VAT and from 1.67 for EEF1A1 to 2.85 for GAPDH in SAT. Thus, despite being
highly expressed, 18S had the lowest precision in VAT and also a low precision in SAT (2.77).
By contrast, EEF1A1 had a high expression in VAT and SAT in combination with a high preci-
sion (low±2SD values). RPL13A, despite having moderate expression in VAT and SAT also
showed a high precision in both VAT and SAT (1.39 and 1.79 for ±2SD values, respectively).
We assessed variability of gene expression during differentiation by comparing the ΔCt val-
ues in samples from the same patients before and after differentiation (Fig 4). The criterion of
ΔCt value ± 0.5 was used as a delimiter of reference gene suitability during differentiation.
All data were converted into fold-changes using the formula 2-ΔCt; and, accordingly, values that
filled in between 0.7 and 1.4 suggested that there were no significant differences between
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Fig 1. Adipogenic differentiation of hVSCs from VAT and SAT of subjects with different BMI and
HOMA-IR index. A) Representative photomicrographs of undifferentiated VAT-derived stromal cells
(VAT-VSCs) and SAT-derived stromal cells (SAT-VSCs) (left column) and differentiated adipocytes from
VAT-VSCs (upper row) and SAT-VSCs (lower row) stained with the lipophilic marker oil red O. The images
show brown spots in samples from all groups, corresponding to lipid accumulation within the newly generated
adipocytes. Due to a technical problem, images from Lean H-IR samples are not available. They were
instead analyzed by RT-PCR. (B and C) mRNA expression of the adipocyte marker PPARγ2 (B) and FABP4
(C) in undifferentiated and differentiated samples corresponding to VAT (left column) and SAT (right column)
from all groups. Gene expression was referred to differentiated lean-Low-IR samples, which were considered
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undifferentiated and differentiated adipocytes (Fig 4). Among the five reference genes,
RPL13A, EEF1A1 and CYC were the most stable reference genes during differentiation in both
VAT and SAT, as most samples displayed fold-changes values between 0.7 and 1.4. In fact,
RPL13A and EEF1A1 were the most stable with 10 and 11 out of 16 samples (for VAT) and 8
and 9 out of 16 samples (for SAT) within this range. By contrast, GAPDH and 18S were the less
stable, showing only 4 and 6 out of 16 samples (for VAT and SAT) within this range.
Validation of these findings was done by BestKeeper analysis and by using the RefFinder
platform. Tables 5 and 6 show the descriptive and regression analysis, respectively, after the
BestKeeper processing. Table 5 shows that, when analyzing the five reference genes in a sepa-
rate manner (left column), GAPDH and 18S have a SD>1. Moreover, they have a [X-fold]
parameter in the regression analysis>2 (Table 6), indicating that both are unsuitable reference
genes. Correlation analysis showed a wide range in the Pearson correlation coefficient
(0.674<r<0.937), suggesting that GAPDH and 18S should not be considered as suitable
(Table 6). Subsequently, when CYC, RPL13A and EEF1A1 were analyzed together by Best-
Keeper; the SD was< to 1 (Table 5, middle column), the Pearson correlation range fill in
between 0.855 and 0.931 (Table 6) and CYC showed X-fold parameter>2 (Table 6), suggesting
that CYC should also be removed.
Next, when RPL13A and EEF1A1 were analyzed together; the SD was<1 (Table 5, middle
column) and the X-fold was 2 (Table 6). Repeated pair-wise correlation analysis showed a high
correlation of these reference genes vs BestKeeper, showing a narrow range of 0.989<r<0.994.
Taken together, these data indicate that RPL13A and EEF1A1 are good reference genes and
they could be used alone or in combination for the analysis of gene expression changes in
human VAT and SAT during adipogenesis.
In order to further validate our results from the BestKeeper analysis, we used the RefFinder
platform, which is a popular tool for reference gene validation that performs a quick analysis
using the four most popular algorithms for reference gene validation (GeNorm, BestKeeper,
NormFinder and ΔCt method), starting from a single input of the Ct values. In this case, we
obtained similar results than that of the BestKeeper (Table 5, right column). The first analysis
of the five reference genes led to a similar ranking for RPL13A, EEF1A1 and CYC, suggesting
that GAPDH and 18S should be removed. Subsequent analysis of the three selected reference
genes led to removal of CYC, indicating that RPL13A and EEF1A1 were the most suitable genes
and thus confirming our previous results.
Discussion
qPCR gene expression analysis is a widely used technique to determine differences in gene
expression between samples [26]. To exclude any artifactual interpretation, the technique
as 100%; RPL13Awas used as reference gene. Data represent mean ± SEM of four samples in each bar.
FABP4 expression in undifferentiated samples could not be detected in our assay (N.D.). Both PPARγ2 and
FABP4 expression were dramatically increased in samples from differentiated cells, being higher in samples
frommorbid obese when compared to lean subjects, independently of the associated insulin resistance
condition, (MO L-IR or MO H-IR versus Lean L-IR or Lean H-IR). Additionally, PPARγ2 levels in VAT were
different in each group when compared to any other, with expression levels decreasing in the following way,
MO H-IR>MO L-IR>Lean H-IR>Lean L-IR (Two-way ANOVA and Bonferroni post-hoc test. Asterisks
represent comparisons between undifferentiated and differentiated samples within each study group; hashes
represent comparisons among differentiated samples from different study groups). VAT: visceral adipose
tissue; SAT: subcutaneous adipose tissue; VAT-VSCs: stromal cells derived from visceral adipose tissue;
SAT-VSCs: stromal cells derived from subcutaneous adipose tissue; Lean L-IR: lean subjects with low-
degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR: morbid
obese subjects with low-degree insulin resistance; MO H-IR: morbid obese with high-degree insulin
resistance.
doi:10.1371/journal.pone.0157002.g001
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Fig 2. Boxplots of mRNA expression for RPL13A, EEF1A1,CYC,GAPDH and 18S from
undifferentiated and differentiated cells.Raw non-normalized Ct values from qPCRwere collected and
analyzed to look for differences in absolute gene expression among groups and fat depots. Data were
grouped to compare Ct of lean versus morbid obese (low-IR + high-IR) in VAT (A) and SAT (C), low-IR versus
high-IR (lean + morbid obese) in VAT (B) and SAT (D), and VAT versus SAT (E). Ct values are represented in
boxplots as median and 2.5–97.5 percentile; n = 8 samples in each group except in VAT versus SAT, where
n = 16 in each group. No changes among groups were detected for any tissue and reference gene
investigated. Two-way ANOVA. VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue. MO:
morbid obese; L-IR: low-degree insulin resistance; H-IR: high-degree insulin resistance.
doi:10.1371/journal.pone.0157002.g002
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Table 3. Descriptive analysis of Ct values variability from qPCR of undifferentiated and differentiated hVSCs from SAT of patients with different
BMI and HOMA-IR index. The table shows the statistics min, max, mean±SEM, standard variation (SD) and variance of the Ct values obtained after qPCR
of undifferentiated and differentiated SAT-derived hVSCs in the four groups under investigation as well as the mean values for every reference gene
assessed (right columns). Data show that RPL13A and EEF1A1 has the lowest variability (SD and variance values) suggesting more stability in their expres-
sion when compared to the other reference genes. VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue. Lean L-IR: lean subjects with low-
degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR: morbid obese subjects with low-degree insulin resistance;
MO H-IR: morbid obese with high-degree insulin resistance.
RPL13A in SAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 22.37 23.63 23.06 22.78 22.42 22.35 22.79 22.24 22.70
Max 25.85 24.67 24.06 24.08 24.40 23.69 25.79 25.80 24.79
Mean ±SEM 23.88±0.72 23.96±0.24 23.52±0.23 23.42±0.27 23.49±0.41 23.20±0.31 23.61±0.73 23.80±0.81 23.61±0.46
SD 1.44 0.48 0.45 0.54 0.82 0.62 1.45 1.62 0.93
Variance 2.09 0.24 0.21 0.29 0.66 0.39 2.12 2.63 1.08
EEF1A1 in SAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 17.28 17.09 17.04 17.54 18.02 17.71 17.30 17.05 17.38
Max 18.31 19.01 18.72 18.78 20.48 21.13 19.65 18.06 19.27
Mean ±SEM 17.87±0.22 17.95±0.44 17.87±0.35 18.19±0.26 18.76±0.58 18.96±0.79 18.10±0.54 17.64±0.21 18.17±0.42
SD 0.43 0.89 0.69 0.52 1.17 1.58 1.08 0.42 0.85
Variance 0.19 0.79 0.48 0.27 1.36 2.49 1.18 0.18 0.87
CYC in SAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 21.89 23.04 22.79 22.47 22.54 23.06 22.97 23.22 22.75
Max 25.54 26.04 25.14 24.88 25.65 25.27 25.56 25.86 25.49
Mean ±SEM 23.67±0.82 24.38±0.64 23.63±0.54 24.06±0.54 23.82±0.65 24.2±0.56 24.50±0.56 24.56±0.54 24.10±0.6
SD 1.64 1.29 1.09 1.08 1.31 1.12 1.12 1.09 1.22
Variance 2.69 1.67 1.18 1.17 1.71 1.26 1.26 1.18 1.52
GAPDH in SAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 25.53 22.86 23.96 22.86 25.30 22.88 24.89 24.59 24.11
Max 28.19 26.56 27.08 28.16 25.79 26.24 27.59 27.61 27.15
Mean ±SEM 26.61±0.6 25.06±0.78 25.43±0.64 25.97±1.3 25.60±0.11 24.69±0.72 26.22±0.61 25.98±0.64 25.69±0.67
SD 1.19 1.56 1.29 2.59 0.23 1.44 1.22 1.28 1.35
Variance 1.43 2.45 1.67 6.73 0.05 2.07 1.5 1.65 2.19
18S in SAT
Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
Undiff Diff Undiff Diff Undiff Diff Undiff Diff
Min 12.08 10.22 10.34 12.27 11.70 12.40 12.86 12.47 11.79
Max 16.42 13.88 15.45 16.22 14.06 13.54 14.54 13.87 14.75
Mean ±SEM 14.27±1.17 12.47±0.81 13.14±1.14 14.29±0.81 12.83±0.59 13.07±0.26 13.45±0.39 13.16±0.29 13.33±0.68
SD 2.35 1.63 2.28 1.62 1.19 0.52 0.78 0.57 1.37
Variance 5.5 2.65 5.22 2.64 1.41 0.27 0.61 0.33 2.33
doi:10.1371/journal.pone.0157002.t003
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Fig 3. Variability of gene expression among groups and fat depots.Raw non-normalized Ct values from qPCR were collected and
processed in the following way: Difference of Ct from RPL13A, EEF1A1, CYC,GAPDH and 18S to the average of the remaining genes
was calculated for all samples from lean L-IR (white circles), Lean H-IR (black circles), MO L-IR (white triangles) and MOH-IR (black
triangles) in VAT and SAT and plotted for a visual comparison of samples among groups. Full line represents mean difference and
dashed lines illustrate precision as 2-fold standard deviation (±2SD). VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue.
Lean L-IR: lean subjects with low-degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR:
morbid obese subjects with low-degree insulin resistance; MO H-IR: morbid obese with high-degree insulin resistance. For further
information see also Table 4.
doi:10.1371/journal.pone.0157002.g003
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requires solid normalization strategies. Among the available normalization methods, the use of
reference genes is currently the preferred method [27]. The use of inappropriate reference
genes is a widely accepted cause of misinterpretation of the results [28]. The expression stability
of the reference gene determines the sensitivity and reliability of mRNA quantification by
qPCR [29]. Notably, studies of well-known reference genes such as GADPH and β-ACT show
considerable variation in their expression levels depending on the tissue type and experimental
conditions [30]. Particularly, in VAT and SAT, the expression of these genes is unstable while
comparing samples from healthy subjects with those from patients with obesity and type 2 dia-
betes mellitus [31], this thus highlighting the need of validated reference genes for these sort of
studies. Also, a study in human epicardial AT from lean, overweight and obese subjects identi-
fied CYCA, GAPDH and RPL27 as the most stable genes [32]. To the best of our knowledge,
there are current no validated reference genes for studies performed in human hVSCs from
VAT and SAT isolated from subjects with different BMI and/or HOMA-IR. Here, we analyzed
for the first time five putative reference genes (RPL13A, EEF1A1, CYC, GAPDH and 18S), com-
monly used for the analysis of adipocyte differentiation from hVSCs or cell lines. hVSCs from
VAT and SAT isolated from subjects with different BMI and/or HOMA-IR were differentiated
into adipocytes. Both oil red O-staining and FABP4/PPARγ2mRNA expression analyzes con-
firmed the successful adipocyte differentiation. On the other hand, even if PPARγ2 and FABP4
mRNA expression levels were found to be higher in samples from obese patients (two-way
ANOVA) compared to those from leans, it still debatable to confirm or to rule out that hVSC
from obese subjects displayed higher adipocyte differentiation compared to lean, due to the
small sample number used in this study. Further analysis with greater sample number should
be carried out to investigate this fact. It is relevant to highlight that the goal of this study was to
analyze whether the level of adipocyte differentiation might affect the variance of the reference
Table 4. Mean difference values and precision of gene expression in samples from patients with different BMI and HOMA-IR index. Themean differ-
ence (MD) for each sample was calculated as the difference of Ct from RPL13A, EEF1A1, CYC,GAPDH and 18S to the average of the other four genes and
tissues. Then, the difference was averaged separately for each group (Lean L-IR, Lean H-IR, MO L-IR, MO H-IR). The right column represents the mean val-
ues for the four groups. The precision was calculated as 2-fold standard deviation (±2SD). No statistical differences for MD were found among groups (one-
way ANOVA). Expression levels for VAT were 18S>EEF1A1>CYC>RPL13A>GAPDH, and those of SAT were 18S>EEF1A1>RPL13A>CYC>GAPDH. Preci-
sion ranged from 1.39 for RPL13A to 2.86 for 18S in VAT and from 1.67 for EEF1A1 to 2.85 forGAPDH in SAT. VAT: visceral adipose tissue; SAT: subcutane-
ous adipose tissue. Lean L-IR: lean subjects with low-degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR:
morbid obese subjects with low-degree insulin resistance; MO H-IR: morbid obese with high-degree insulin resistance.
VAT
Gene Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
MD ± 2 SD MD ± 2 SD MD ± 2 SD MD ± 2 SD MD ± 2 SD
RPL13A 3.26 1.55 4.82 1.16 4.06 1.93 2.86 0.92 3.75 1.39
EEF1A1 -3.14 1.74 -3.47 1.12 -2.26 2.15 -3.03 1.35 -2.98 1.59
CYC 3.45 3.41 2.52 1.49 3.44 2.75 3.28 1.79 3.17 2.36
GAPDH 6.00 3.85 4.16 2.86 5.00 2.25 5.73 2.33 4.42 2.82
18S -9.56 2.63 -8.03 2.23 10.23 3.53 -8.84 3.03 -9.17 2.86
SAT
Gene Lean L-IR Lean H-IR MO L-IR MO H-IR MEAN
MD ± 2 SD MD ± 2 SD MD ± 2 SD MD ± 2 SD MD ± 2 SD
RPL13A 3.63 2.00 3.15 0.93 3.10 1.38 3.26 2.86 3.29 1.79
EEF1A1 -3.88 1.29 -3.65 1.19 -2.50 2.58 -4.04 1.61 -3.51 1.67
CYC 3.77 2.84 3.62 2.06 3.94 2.29 4.28 2.05 3.90 2.31
GAPDH 6.03 3.07 5.94 3.84 5.35 2.14 6.25 2.34 5.89 2.85
18S -9.55 4.20 -9.07 3.85 -9.89 1.72 -9.75 1.31 -9.56 2.77
doi:10.1371/journal.pone.0157002.t004
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Fig 4. Gene expression stability during differentiation in VAT and SAT samples from subjects with different BMI and HOMA-IR
index. hVSCs from VAT and SAT of subjects with different BMI and HOMA-IR index were induced to differentiate, and mRNA
expression of RPL13A, EEF1A1, CYC,GAPDH and 18S was analyzed by qPCR. Change in gene expression during differentiation was
estimated by calculating 2-ΔCt, where ΔCt = (mean Ct in differentiated sample—mean Ct in undifferentiated sample). Dashed lines
represent limits for 2-ΔCt acceptable values; those that fall in between 0.7 and 1.4 can be considered fluctuation in gene expression that
are due to technical variance. Each bar represents mean expression in one single sample. Error bars have been omitted for clarity
purposes. It can be seen that in both VAT and SAT the number of samples within the acceptable range is higher for RPL13A, EEF1A1
andCYC than forGAPDH and 18S. VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue. Lean L-IR: lean subjects with low-
degree insulin resistance; Lean H-IR: lean subjects with high-degree insulin resistance; MO L-IR: morbid obese subjects with low-degree
insulin resistance; MO H-IR: morbid obese with high-degree insulin resistance.
doi:10.1371/journal.pone.0157002.g004
Table 5. Descriptive statistics of the five candidate reference genes, calculated BestKeeper Index and comparative analysis with RefFinder. Data
of expression for the five candidate reference genes (RGs), based on their crossing point (CP) values, were introduced in BestKeeper software. The result of
descriptive analysis for every gene is showed in the left column. The Bestkeeper index was calculated for five genes (RPL13A, EEF1A1, CYC,GAPDH and
18S), for three genes (RPL13A, EEF1A1 andCYC) and for two genes (RPL13A and EEF1A1) (middle column). Data for the combination of 5 and 3 RGs were
introduced in the RefFinder tool and the results are shown in the right column. Geometric Mean (GM), Arithmetic Mean (AM), Minimum (Min) and Maximum
(Max) Crossing Point value (CP), Standard Deviation (SD) and Coefficient of Variation (CV) * indicates when the value is out of range.
BESTKEEPER: DESCRIPTIVE ANALYSIS (CP) BESTKEEPER INDEX RANKING REFFINDER
RPL13A EEF1A1 CYC GAPDH 18s 5 RG 3 RG 2 RG RG 5 RG 3 RG
GM 23.64 18.26 23.5 25.3 12.9 20.7 21.81 20.77 RPL13A 1.86 1.41
AM 23.65 18.27 23.6 25.34 13.16 20.8 21.83 20.79 EEF1A1 1.68 1.19
Min 22.24 17.05 21.1 22.86 4.4 17.5 20.14 19.47 CYC 1.73 3
Max 26.02 21.13 26.8 28.19 16.42 23.7 24.64 23.45 GAPDH 3.72
SD ± 0.49 0.48 0.85 1.07 * 1.31* 0.84 0.61 0.48 18s 5
CV % 2.06 2.61 3.61 4.24 9.98 4.5 2.77 2.3
doi:10.1371/journal.pone.0157002.t005
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genes. Thus, suitable reference genes should be those not affected by changes in the level of
differentiation.
We have performed our own analysis of gene expression level, variability among groups and
gene expression stability by analyzing raw non-normalized Ct values and change in Ct values
during differentiation. Furthermore, we have validated our findings by using BestKeeper analy-
sis and the RefFinder platform. Taken together, the analysis suggests that RPL13A and EEF1A
are the most reliable and stable reference genes for these tissues and patient types. The Best-
keeper analysis also suggested that the combination of these two reference genes can provide a
more robust method than using them separately.
Our findings agree with a previous study showing that RPL13A is the most stable reference
gene for adipose tissue- and Wharton’s Jelly-derived human MSCs expansion and differentia-
tion analysis [11]. In fact, RPL13A in combination with GAPDH [13] or EEF1A1 and 18S [15]
has been found to be appropriate for the analysis of gene expression during adipogenesis of
mesenchymal stem cells from bone marrow cells [13,15] or VAT 11]. On the other hand, the
18S has been used as reference gene for SAT [16,17]. However, there are no studies validating
it. Our study shows that changes in the expression of the 18S gene during adipocyte differentia-
tion are higher than expected, thus suggesting that it is not suitable as reference gene in this
process. By contrast, our study confirms that RPL13A and EEF1A1 are stable reference genes
for VAT or SAT samples from subjects with different degrees of obesity and IR. Furthermore,
we found that, together with 18S, GAPDH and CYC were not suitable reference genes for these
experimental conditions, which is in agreement with other study [33]. Another study also
found that the combination of 18S, EF1-α and β-ACT is not suitable for the analysis of VEGF-
treated human MSCs from bone marrow and AT [34]. Our data also support the combined use
of reference genes, which is in agreement with a previous report [35].
Table 6. Regression Analysis from the BestKeeper. Data represent pair-wise correlation analysis of the reference genes (RGs) versus the BestKeeper
index (BK) of 5.3 or 2 RGs. The first five lines represent the analysis of every gene versus the BK calculated for the five genes. Next three lines represent the
analysis of every gene versus the BK calculated for the three genes. Last two lines represent the analysis of every gene versus the BK calculated for the two
genes.
RG vs. BK PEARSON'S COEFF.
[r]
COEFFICIENT of DETERM.
[r2]
INTERCEPTION
[CP]
SLOPE
[CP]
SE
[CP]
p-
value
POWER [X-
fold]
RPL13A vs. BK
(5RG)
0.674 0.454 12.237 0.561 ± 0.545 0.001 1.47
EEF1A1 vs. BK
(5RG)
0.715 0.511 5.702 0.617 ± 0.536 0.001 1.53
CYC vs. BK (5RG) 0.937 0.878 -1.259 1.223 ± 0.404 0.001 2.33*
GAPDH vs. BK
(5RG)
0.696 0.484 3.823 1.063 ± 0.973 0.001 2.09*
18S vs. BK (5RG) 0.833 0.694 -12.666 1.286 ± 0.757 0.001 2.44*
RPL13A vs. BK
(3RG)
0.92 0.846 5.186 0.852 ± 0.286 0.001 1.81
EEF1A1 vs. BK
(3RG)
0.931 0.867 -1.16 0.897 ± 0.277 0.001 1.86
CYC vs. BK (3RG) 0.855 0.731 -3.646 1.256 ± 0.599 0.001 2.39*
RPL13A vs. BK
(2RG)
0.989 0.978 3.529 0.968 ± 0.108 0.001 1.96
EEF1A1 vs. BK
(2RG)
0.994 0.988 -2.771 1.012 ± 0.083 0.001 2.02
* indicates that the gene showed an [x-fold] out of range (>2). GAPDH and 18S were discarded after the first analysis. CYC was discarded after the
second analysis.
doi:10.1371/journal.pone.0157002.t006
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We could not detect significant changes in the expression level among groups for any of the
reference genes studied. However, we cannot rule out this possibility, because the sample size is
small when the patients are classified according to body weight and HOMA-IR index (n = 4
each group). However, the analysis of Ct values for lean vs obese (n = 8), low-IR vs high-IR
(n = 8) and VAT vs SAT (n = 16) did not either detect changes between them.
In conclusion, we show for the first time that EEF1A1 and RPL13A are stable reference
genes during adipogenic differentiation of VAT and SAT human samples. Thus, they are suit-
able for gene expression studies of VAT and SAT-derived stem cells from subjects with differ-
ent degrees of obesity and IR. The use of these genes in pair combinations may further enhance
the strength of the data obtained from gene expression analysis in this cellular system.
Supporting Information
S1 Table. TaqMan1 probe’s references from Applied Biosystems.
(DOCX)
Author Contributions
Conceived and designed the experiments: RE. Performed the experiments: AMG SL LCA
WOOHZ JM SYRZ. Analyzed the data: RE FJBS AMG AVR JM SYRZ. Wrote the paper: RE
FJBS AMG AVR. Recruited and carried out the surgeries: FJT.
References
1. Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipo-
genesis. Trends Endocrinol Metab. 2015 Apr; 26(4):193–200. doi: 10.1016/j.tem.2015.01.006 PMID:
25703677
2. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabe-
tes. Nature. 2006 Dec 14; 444(7121):840–846. PMID: 17167471
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006 Jul; 116
(7):1793–1801. PMID: 16823477
4. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome—An allo-
static perspective. Biochim Biophys Acta—Mol Cell Biol Lipids. 2010 Mar; 1801(3):338–349.
5. Guilherme A, Virbasius J V, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resis-
tance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008 May; 9(5):367–377. doi: 10.1038/nrm2391
PMID: 18401346
6. Farrokhi A, Eslaminejad MB, Nazarian H, Moradmand A, Samadian A, Akhlaghi A. Appropriate refer-
ence gene selection for real-time PCR data normalization during rat mesenchymal stem cell differentia-
tion. Cell Mol Biol. 2012 Jan; 58 Suppl:OL1660–1670. PMID: 22595340
7. Song J, Bai Z, HanW, Zhang J, Meng H, Bi J, et al. Identification of suitable reference genes for qPCR
analysis of serummicroRNA in gastric cancer patients. Dig Dis Sci. 2012 Apr; 57(4):897–904. doi: 10.
1007/s10620-011-1981-7 PMID: 22198701
8. Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum
information for publication of quantitative real-time PCR experiments. Clin Chem. 2009 Apr; 55(4):611–
622. doi: 10.1373/clinchem.2008.112797 PMID: 19246619
9. Klie M, Debener T. Identification of superior reference genes for data normalisation of expression stud-
ies via quantitative PCR in hybrid roses (Rosa hybrida). BMC Res Notes. 2011 Jan; 4:518. doi: 10.
1186/1756-0500-4-518 PMID: 22123042
10. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normaliza-
tion of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
Genome Biol. 2002 Jun 18; 3(7):RESEARCH0034. PMID: 12184808
11. Amable PR, Teixeira MVT, Carias RBV, Granjeiro JM, Borojevic R. Identification of appropriate refer-
ence genes for humanmesenchymal cells during expansion and differentiation. PLoS One. 2013; 8(9):
e73792. doi: 10.1371/journal.pone.0073792 PMID: 24023904
RPL13A and EEF1A1 As Reference Genes for Adipocyte Differentiation
PLOS ONE | DOI:10.1371/journal.pone.0157002 June 15, 2016 16 / 18
12. Seo K-W, Roh K-H, Bhandari DR, Park S-B, Lee S-K, Kang K-S. ZNF281 knockdown induced osteo-
genic differentiation of humanmultipotent stem cells in vivo and in vitro. Cell Transplant. 2013 Jan; 22
(1):29–40. doi: 10.3727/096368912X654948 PMID: 22963690
13. Köllmer M, Buhrman JS, Zhang Y, Gemeinhart RA. Markers Are Shared Between Adipogenic and
Osteogenic Differentiated Mesenchymal Stem Cells. J Dev Biol tissue Eng. 2013 May 1; 5(2):18–25.
PMID: 24013643
14. Curtis KM, Gomez LA, Rios C, Garbayo E, Raval AP, Perez-Pinzon MA, et al. EF1alpha and RPL13a
represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal
stem cells. BMCMol Biol. 2010 Jan; 11:61. doi: 10.1186/1471-2199-11-61 PMID: 20716364
15. Studer D, Lischer S, JochumW, Ehrbar M, Zenobi-Wong M, Maniura-Weber K. Ribosomal protein l13a
as a reference gene for human bone marrow-derived mesenchymal stromal cells during expansion,
adipo-, chondro-, and osteogenesis. Tissue Eng Part C Methods. 2012 Oct; 18(10):761–771. PMID:
22533734
16. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair
human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology. 2007
Feb; 148(2):868–877. PMID: 17082259
17. Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human
abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes. 2009 Jul; 58
(7):1550–1557. doi: 10.2337/db08-1770 PMID: 19351711
18. Ferguson BS, Nam H, Hopkins RG, Morrison RF. Impact of reference gene selection for target gene
normalization on experimental outcome using real-time qRT-PCR in adipocytes. PLoS One. 2010 Jan;
5(12):e15208. doi: 10.1371/journal.pone.0015208 PMID: 21179435
19. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, et al.
Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population:
effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013 Jan; 13:47. doi: 10.
1186/1472-6823-13-47 PMID: 24131857
20. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose
tissue: implications for cell-based therapies. Tissue Eng. 2001 Apr; 7(2):211–228. PMID: 11304456
21. Roca-Rodríguez MM, El Bekay R, Garrido-Sanchez L, Gómez-Serrano M, Coin-Aragüez L, Oliva-Oli-
vera W, et al. Parathyroid Hormone-Related Protein, Human Adipose-Derived Stem Cells Adipogenic
Capacity and Healthy Obesity. J Clin Endocrinol Metab. 2015 Jun; 100(6):E826–35. doi: 10.1210/jc.
2014-4132 PMID: 25885945
22. Oliva-Olivera W, Coín-Aragüez L, Salas J, Lhamyani S, Gentile A-M, Sarria García E, et al. Myocardial
Ischemic Subject’s Thymus Fat: A Novel Source of Multipotent Stromal Cells. PLoS One. 2015 Jan; 10
(12):e0144401. doi: 10.1371/journal.pone.0144401 PMID: 26657132
23. Yin R, Liu X, Liu C, Ding Z, Zhang X, Tian F, et al. Systematic selection of housekeeping genes for
gene expression normalization in chicken embryo fibroblasts infected with Newcastle disease virus.
Biochem Biophys Res Commun. 2011 Oct 7; 413(4):537–540. doi: 10.1016/j.bbrc.2011.08.131 PMID:
21925148
24. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differ-
entially regulated target genes and sample integrity: BestKeeper—Excel-based tool using pair-wise
correlations. Biotechnol Lett. 2004 Mar; 26(6):509–515. PMID: 15127793
25. Xie F, Xiao P, Chen D, Xu L, Zhang B. miRDeepFinder: a miRNA analysis tool for deep sequencing of
plant small RNAs. Plant Mol Biol. 2012 Jan 31.
26. Fu L-Y, Jia H-L, Dong Q-Z, Wu J-C, Zhao Y, Zhou H-J, et al. Suitable reference genes for real-time
PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer.
2009 Jan; 9:49. doi: 10.1186/1471-2407-9-49 PMID: 19200351
27. Vandesompele J, Kubista M, Pfaffl MW. Reference Gene Validation Software for improved Normaliza-
tion. In Real-time PCR: current technology and applications. Vol. 47. Edited by Logan J, Edwards K,
Saunders N. Norfolk, UK: Caister Academic Press; 2009:64.
28. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, Johnson MA, et al. The implications of using an
inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem.
2005 Sep 1; 344(1):141–143. PMID: 16054107
29. Quiroz FG, Posada OM, Gallego-Perez D, Higuita-Castro N, Sarassa C, Hansford DJ, et al. House-
keeping gene stability influences the quantification of osteogenic markers during stem cell differentia-
tion to the osteogenic lineage. Cytotechnology. 2010 Apr; 62(2):109–120. doi: 10.1007/s10616-010-
9265-1 PMID: 20396946
30. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain
reaction assays. J Mol Endocrinol. 2000 Oct; 25(2):169–193. PMID: 11013345
RPL13A and EEF1A1 As Reference Genes for Adipocyte Differentiation
PLOS ONE | DOI:10.1371/journal.pone.0157002 June 15, 2016 17 / 18
31. Catalán V, Gómez-Ambrosi J, Rotellar F, Silva C, Rodríguez A, Salvador J, et al. Validation of endoge-
nous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabe-
tes mellitus. 2007 Jul; 39(7):495–500.
32. Chechi K, Gelinas Y, Mathieu P, Deshaies Y, Richard D. Validation of reference genes for the relative
quantification of gene expression in human epicardial adipose tissue. PLoS One. 2012 Jan; 7(4):
e32265. doi: 10.1371/journal.pone.0032265 PMID: 22511915
33. Mehta R, Birerdinc A, Hossain N, Afendy A, Chandhoke V, Younossi Z, et al. Validation of endogenous
reference genes for qRT-PCR analysis of human visceral adipose samples. BMCMol Biol. 2010 Jan;
11:39. doi: 10.1186/1471-2199-11-39 PMID: 20492695
34. Tratwal J, Follin B, Ekblond A, Kastrup J, Haack-Sørensen M. Identification of a common reference
gene pair for qPCR in humanmesenchymal stromal cells from different tissue sources treated with
VEGF. BMCMol Biol. 2014 Jan; 15:11. doi: 10.1186/1471-2199-15-11 PMID: 24885696
35. Kozera B, Rapacz M. Reference genes in real-time PCR. J Appl Genet. 2013 Nov; 54(4):391–406.
PMID: 24078518
RPL13A and EEF1A1 As Reference Genes for Adipocyte Differentiation
PLOS ONE | DOI:10.1371/journal.pone.0157002 June 15, 2016 18 / 18
